CLIG (City of London Investment Group PLC) — Investment Research Note

Executive summary

CLIG is a UK-listed active asset manager operating two subsidiaries — CLIM (institutional emerging/international closed-end fund equity) and KIM (US high-net-worth balanced/fixed income) — with $12.3bn FuM at 30 June 2026 2026-09-15 final results. The period saw FuM grow 13.9% (driven by $2.8bn of market/investment performance offsetting $1.3bn net outflows), underlying EPS rise 14.2% to 41.9p, and the cost/income ratio fall from 65.4% to 60.5% — a decent year of operating leverage in a difficult year for boutique active managers. The single most important point for valuation today: this is a debt-free, cash-generative specialty asset manager trading at ~11.5x underlying earnings with a ~7% dividend yield, but the AI thesis is essentially absent and structural fund flows have been persistently negative.

Fair value estimate

• Fair value range: 500p – 600p per share (implied market cap £247m – £296m)
• Methodology: blend of (i) forward P/E of 12–14× underlying EPS of ~42p → 505–590p; (ii) dividend yield of 5.5–6.5% on 34p total dividend → 525–620p; (iii) EV/FuM at 2.5–3.0% (vs Kroll's 3.5% used for KIM goodwill impairment test) + net cash $42m → £260–320m equity → 525–645p; (iv) EV/EBITDA at 7–9× on ~$43m EBITDA + net cash → £220–290m → 445–585p.
• Current market cap: £235.5m at 482p; mid fair value ~550p; implied upside ~14%.
• Key assumptions: stable ~66bps net fee margin, FuM flat-to-slightly-up (market gains offsetting continuing net outflows), overhead cost-to-income at 60% area, 25% effective tax rate. No AI-related re-rating assumed.

Sector context

• Sector confirmed: Financials / Financial Services — specifically boutique active asset management, UK-listed.
• Quality/growth/leverage profile: balance sheet quality above peers (zero debt, $42m cash), growth in line (FuM growth driven by markets, structural net outflows in line with active industry), operating leverage above average for asset managers because ~29% of costs are GBP-denominated fixed overhead against a USD-denominated fee base.
• Listed peers: Liontrust Asset Management (LIO), Polar Capital (POLR), Ashmore (ASHM) — the latter being the closest EM-fee-margin comparator.

Investment thesis (3 bullets)

• Fortress balance sheet plus 7% yield, priced modestly: $42m net cash (~£31m), no debt, progressive dividend policy replacing the old 1.2x-cover rule, and stated intention to keep growing distributions — attractive income for a UK small-cap financial 2026-09-15 final results.
• Operating leverage is finally showing: overhead-to-income ratio dropped from 40.0% to 36.6% and operating margin expanded from 34.6% to 39.5% year-on-year despite the USD weakening 3.5% against sterling (a headwind since ~29% of costs are GBP). Continued cost discipline plus any FuM tailwind would drop disproportionately to profit 2026-09-15 final results, Financial Review.
• KIM diversification is doing what it was designed to do: 5 years after the 2020 merger, EM equity is only ~34% of Group FuM (vs. ~90% pre-2016) and the fixed-income/balanced KIM strategies are outperforming — this materially reduces the historical volatility of earnings and provides some defensive underpinning when EM equity sentiment turns 2026-09-15 final results, Chair's Statement.

Key risks (3 bullets)

• Structural net outflows: Group net outflows of $1.3bn in FY26 (13.5% of opening FuM), including $872m from EM equity — flows have been negative every year since FY22 and only market returns have kept FuM growing 2026-09-15 final results, Investment and Business Review. The passive-vs-active trend the CEO himself calls out is a persistent structural headwind.
• Fee margin erosion: net fee margin declined from 68bps to 66bps this year on "fee mix"; asset-manager fee compression is a well-documented industry trend and CLIG has limited pricing power 2026-09-15 Financial Review.
• Market/EM beta: revenues scale directly with FuM which scales with equity markets. A 20% EM/international drawdown would take ~10–13% off Group FuM and roughly the same off revenue, with an outsized hit to profit given fixed costs (inferred from cost structure disclosed in filings).

Operating leverage

The economics here are attractive for a modest re-rating on FuM growth but nothing like a software business. Fee income is essentially a % of FuM (net fee margin ~66bps in FY26) — nearly all revenue is variable to markets. Costs are more mixed: employee costs $31.1m plus other admin $8.7m plus D&A $6.5m = $46.3m total operating cost. Of these, ~$10.3m is discretionary/variable bonus, so the truly "fixed" cost base is closer to $35–36m per year. That gives an incremental contribution margin on new FuM of roughly 60–70% (net fee less bonus). A 10–20% upside FuM surprise (say $12.3bn → $14bn) at 66bps drops roughly $11m of revenue with maybe $7–8m falling to operating profit — a ~25% uplift on FY26's $30m operating profit. That's meaningful but not "multiples of profit" — this is a 60/100-ish operating-leverage business, not a software business 2026-09-15 Financial Review; consolidated income statement.

Value-trap signals

• Persistent net outflows across four consecutive financial years, especially in the flagship EM strategy which is the highest-margin book.
• Fee margin erosion trend (68bps → 66bps in one year on mix effects).
• Amortisation of $5.6m/year for KIM intangibles continues through 2035 — reduces reported EPS vs. underlying and is a reminder that the KIM goodwill ($90m) sits against a business whose FuM growth since merger has been below original underwriting.
• Structural pressure from passive: CEO himself notes globally passive has gathered $9tn while active has bled $600bn over the past decade 2026-09-15 CEO Statement.
• Not a terminal decline and dividend is well-covered, but these are real value-trap flags — the stock is cheap for reasons, not just mispriced.

Earnings vs. expectations

The filings provide limited explicit consensus data. What is disclosable across the period: FY26 delivered underlying PBT +19.3% and EPS +14.2% (a beat vs. the July 2025 pre-close which had only guided to FuM of $10.8bn and a dividend "in line with previous year" — the final dividend was ultimately raised 1p 2025-07-24 pre-close vs. 2026-09-15 final results). FY25 delivered underlying EPS +9.6% after a July 2024 pre-close that guided to a maintained dividend — a modest beat. FY24 underlying EPS declined ~5% vs. FY23, broadly in line with the July 2023 pre-close guide. Pattern: management is conservative in pre-close guidance, then delivers slight beats when markets cooperate — more beats than misses over the 5-year window, but heavily conditional on market direction.

Conviction

Conviction: 4 (high). Anchors: (i) clean, well-audited financials with 20 years of listing history; (ii) simple business model where fair value is anchored to FuM × fee margin × cost structure — multiple methodologies (P/E, dividend yield, EV/FuM, EV/EBITDA) all converge on ~500–600p; (iii) the KIM CGU impairment test uses a comparable-companies EV/FuM of 3.5% and EV/EBITDA of 9–10x — those disclosed multiples are the same we'd use externally. Limiters: (i) fee margin and flow trajectory are genuinely uncertain — a 10bps hit to net fee margin is a 15% profit hit; (ii) the incoming CEO Cooper Abbott is only 8 months in and any strategic pivot is not yet visible in results.

Overall assessment for the strategy

CLIG scores as a partial fit at best. It's a well-run, cheap, dividend-yielding UK small-cap financial with a fortress balance sheet — but the investor profile explicitly wants AI receivers with operating leverage to a long-tail upside. CLIG is neither. It's a value/income holding, not a growth/AI holding. The stock is fair-to-slightly-cheap but does not have any credible AI-receiver angle (the CEO's own commentary is that AI is a market theme they're trading around, not a driver of their revenue). Operating leverage is real but modest. Downside protection is genuinely good. Overall score reflects "interesting quality-value holding but wrong strategy fit."